Similarly, it has been reported that 60% and 45% of breast cancers occurring in MSH2 and MLH1 mutation carriers respectively were MSI high, whereas all breast cancers in MSH6 mutation carriers were MSS[22]. Here, MLH1 is linked to breast cancer.